232 related articles for article (PubMed ID: 1539780)
1. Torsade de pointes and long QT syndrome following major blood transfusion.
Kulkarni P; Bhattacharya S; Petros AJ
Anaesthesia; 1992 Feb; 47(2):125-7. PubMed ID: 1539780
[TBL] [Abstract][Full Text] [Related]
2. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesaemia causing QT interval prolongation and torsade de pointes in an alcoholic patient.
Gonzalez MM; Cavalcanti TC; Vianna CB; Timerman S
Resuscitation; 2006 Sep; 70(3):346-7. PubMed ID: 16901607
[No Abstract] [Full Text] [Related]
4. A practical approach to torsade de pointes.
Roden DM
Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
[TBL] [Abstract][Full Text] [Related]
5. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
Uvelin A; Pejaković J; Mijatović V
J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
[TBL] [Abstract][Full Text] [Related]
6. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
[TBL] [Abstract][Full Text] [Related]
7. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
[TBL] [Abstract][Full Text] [Related]
8. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
9. Extreme QT interval prolongation and helicoid ventricular tachycardia (torsade de pointes) in non-ST-elevation acute coronary syndrome.
Vilaseca-Corbera M; Vázquez-Oliva G; Campoamor-Cela C; Zamora-Cervantes A; Bassanyanes-Vilarrasa J; Massa-Puig R
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):294-6. PubMed ID: 21813230
[No Abstract] [Full Text] [Related]
10. Long QT syndrome and torsade de pointes in transient left ventricular apical ballooning syndrome.
Denney SD; Lakkireddy DR; Khan IA
Int J Cardiol; 2005 Apr; 100(3):499-501. PubMed ID: 15837097
[TBL] [Abstract][Full Text] [Related]
11. Torsade de pointes.
El-Sherif N; Turitto G
Curr Opin Cardiol; 2003 Jan; 18(1):6-13. PubMed ID: 12496496
[TBL] [Abstract][Full Text] [Related]
12. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
[TBL] [Abstract][Full Text] [Related]
13. Acquired long QT syndrome and torsade de pointes.
El-Sherif N; Turitto G; Boutjdir M
Pacing Clin Electrophysiol; 2018 Apr; 41(4):414-421. PubMed ID: 29405316
[TBL] [Abstract][Full Text] [Related]
14. Torsade de pointes: the clinical considerations.
Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy for torsade de pointes.
Banai S; Tzivoni D
J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
[TBL] [Abstract][Full Text] [Related]
16. Torsades de pointes: a case with multiple variables.
Khan IA; Win MT; Bali AJ; Vasavada BC; Sacchi TJ
Am J Emerg Med; 1999 Jan; 17(1):80-5. PubMed ID: 9928709
[TBL] [Abstract][Full Text] [Related]
17. Treatment of torsade de pointes with intravenous magnesium in idiopathic long QT syndrome.
Hasegawa J; Takami T; Kaneda T; Yamane W; Hoshio A; Igawa O; Fujimoto Y; Kotake H; Mashiba H
Jpn Circ J; 1991 Nov; 55(11):1057-60. PubMed ID: 1749066
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms underlying the long QT syndrome.
Antzelevitch C; Shimizu W
Curr Opin Cardiol; 2002 Jan; 17(1):43-51. PubMed ID: 11790933
[TBL] [Abstract][Full Text] [Related]
19. Torsades de pointes and long QT syndromes.
Janeira LF
Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
[TBL] [Abstract][Full Text] [Related]
20. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
